Literature DB >> 15121159

Human genomics and its impact on arrhythmias.

Dan M Roden1.   

Abstract

Investigation of families with monogenic arrhythmia syndromes has identified genes whose further study has proven extraordinarily valuable in further understanding variability in cardiac electrophysiology and its response to exogenous stressors. One lesson being learned from this work is that individuals from the same kindred with the same disease-associated DNA variant may nevertheless display strikingly different phenotypes. Further, common function-altering polymorphisms are being identified in these and other genes controlling cardiac excitability. These findings, combined with the recognition that very common arrhythmia syndromes (such as atrial fibrillation or sudden arrhythmic death) include a genetic component, raise the prospect that analysis of genomic variability among individuals and populations may in the future be used to manage patients

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121159     DOI: 10.1016/j.tcm.2004.01.001

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  13 in total

1.  Systems pharmacology of arrhythmias.

Authors:  Seth I Berger; Avi Ma'ayan; Ravi Iyengar
Journal:  Sci Signal       Date:  2010-04-20       Impact factor: 8.192

2.  A truly new view from the summit: from translational science to outcomes research in clinical arrhythmology.

Authors:  Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2010-01       Impact factor: 1.900

3.  Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction.

Authors:  Dan Hu; Sami Viskin; Antonio Oliva; Tabitha Carrier; Jonathan M Cordeiro; Hector Barajas-Martinez; Yuesheng Wu; Elena Burashnikov; Serge Sicouri; Ramon Brugada; Rafael Rosso; Alejandra Guerchicoff; Guido D Pollevick; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2007-04-10       Impact factor: 6.343

4.  Association of 14-3-3 proteins to beta1-adrenergic receptors modulates Kv11.1 K+ channel activity in recombinant systems.

Authors:  Antonio S Tutor; Eva Delpón; Ricardo Caballero; Ricardo Gómez; Lucía Núñez; Miguel Vaquero; Juan Tamargo; Federico Mayor; Petronila Penela
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

5.  Absence of family history and phenotype-genotype correlation in pediatric Brugada syndrome: more burden to bear in clinical and genetic diagnosis.

Authors:  Houria Daimi; Amel Haj Khelil; Khaldoun Ben Hamda; Amelia Aranega; Jemni B E Chibani; Diego Franco
Journal:  Pediatr Cardiol       Date:  2015-03-11       Impact factor: 1.655

Review 6.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

7.  Genetic predisposition and cellular basis for ischemia-induced ST-segment changes and arrhythmias.

Authors:  Dan Hu; Sami Viskin; Antonio Oliva; Jonathan M Cordeiro; Alejandra Guerchicoff; Guido D Pollevick; Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2007 Nov-Dec       Impact factor: 1.438

8.  Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification.

Authors:  Elena Sommariva; Carlo Pappone; Filippo Martinelli Boneschi; Chiara Di Resta; Maria Rosaria Carbone; Erika Salvi; Pasquale Vergara; Simone Sala; Daniele Cusi; Maurizio Ferrari; Sara Benedetti
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

9.  A new method for detection and quantification of heartbeat parameters in Drosophila, zebrafish, and embryonic mouse hearts.

Authors:  Martin Fink; Carles Callol-Massot; Angela Chu; Pilar Ruiz-Lozano; Juan Carlos Izpisua Belmonte; Wayne Giles; Rolf Bodmer; Karen Ocorr
Journal:  Biotechniques       Date:  2009-02       Impact factor: 1.993

10.  SCN5A mutation associated with acute myocardial infarction.

Authors:  Antonio Oliva; Dan Hu; Sami Viskin; Tabitha Carrier; Jonathan M Cordeiro; Hector Barajas-Martinez; Yusheng Wu; Elena Burashnikov; Ramon Brugada; Rafael Rosso; Alexandra Guerchicoff; Guido Pollevick; Vincenzo L Pascali; Charlie Antzelevitch
Journal:  Leg Med (Tokyo)       Date:  2009-04-02       Impact factor: 1.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.